{"id":"NCT02628626","sponsor":"Mayo Clinic","briefTitle":"A Study of Colesevelam in Fecal Incontinence","officialTitle":"A Placebo Controlled Study of Colesevelam in Fecal Incontinence","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11","primaryCompletion":"2022-04-14","completion":"2022-04-14","firstPosted":"2015-12-11","resultsPosted":"2023-06-22","lastUpdate":"2023-06-22"},"enrollment":88,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Fecal Incontinence","Bile Acid Malabsorption"],"interventions":[{"type":"DRUG","name":"Colesevelam","otherNames":["Welchol"]},{"type":"DRUG","name":"Clonidine","otherNames":["Catapres"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Colesevelam and Clonidine","type":"ACTIVE_COMPARATOR"}],"summary":"Compare the effects of a combination of colesevelam and clonidine to placebo on bowel symptoms in patients with urge or combined type of FI.","primaryOutcome":{"measure":"Number of Participants to Report a 50% or Greater Reduction in Weekly Fecal Incontinence (FI) Episodes","timeFrame":"4 weeks","effectByArm":[{"arm":"Placebo","deltaMin":17,"sd":null},{"arm":"Colesevelam and Clonidine","deltaMin":13,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.85"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://www.mayo.edu/research/clinical-trials"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":32},"commonTop":["Difficulty swallowing pills","Intercurrent Illness","Nausea and bloating","Insomnia"]}}